Alnylam Pharmaceuticals | ALNY - Trade Creditors



Alnylam Pharmaceuticals reported $102.39M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
Acadia Pharmaceuticals USD 20.1M 2M Jun/2025
Agios Pharmaceuticals USD 17.53M 3.81M Jun/2025
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
Amgen USD 18.03B 15.63B Jun/2025
Arrowhead Research USD 33.05M 23.07M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Incyte USD 1.41B 1.21B Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
Moderna USD 175M 51M Jun/2025
Neurocrine Biosciences 104.6M 5.4M Jun/2025
Novartis USD 4.51B 66M Jun/2025
PTC Therapeutics USD 206.31M 191.16M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Sanofi 7.08B 476M Jun/2025
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
Takeda JPY 421.31B 54.23B Jun/2025
Tectonic Therapeutic USD 2.8M 1.82M Jun/2025
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025
Xencor USD 18.53M 2.34M Jun/2025